Search research articles
Contact Us
Filters
Showing results (301-310 of 945) with videos related to
Page
of 95
Sort By:
Diagnostic Microbiology and Infectious Disease
|
April 1, 1997
Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing
C Jamjian, M S Barrett, R N Jones
Journal of Clinical Microbiology
|
February 1, 1978
Multiple-inocula (replicator) CAMP test for presumptive identification of group B streptococci
P C Fuchs, C Christy, R N Jones
American Journal of Clinical Pathology
|
August 1, 1983
Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines
A L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
August 1, 1995
Evaluation of Vitek and API 20S for species identification of enterococci
H S Sader, D Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease
|
December 1, 1983
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks
R N Jones, A L Barry, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
January 1, 1992
New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria
R N Jones, M E Erwin, M Bale
Diagnostic Microbiology and Infectious Disease
|
February 1, 1996
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials
S Worth, M E Erwin, R N Jones
European Journal of Clinical Microbiology
|
April 1, 1985
Interpretive standards of cefbuperazone disk diffusion susceptibility tests
A L Barry, R N Jones, C Thornsberry
The Journal of Antimicrobial Chemotherapy
|
December 31, 1997
Antimicrobial activity of LB20304, a fluoronaphthyridone, tested against anaerobic bacteria
F Marco, M S Barrett, R N Jones
Lancet (London, England)
|
March 19, 2010
Anuria treated by renal decapsulation and peritoneal dialysis
R REID, J B PENFOLD, R N JONES
Page
of 95
Search research articles
Search
Showing results (301-310 of 945) with videos related to
Sort By:
Page
of 95
Diagnostic Microbiology and Infectious Disease
|
April 1, 1997
Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing
C Jamjian, M S Barrett, R N Jones
Journal of Clinical Microbiology
|
February 1, 1978
Multiple-inocula (replicator) CAMP test for presumptive identification of group B streptococci
P C Fuchs, C Christy, R N Jones
American Journal of Clinical Pathology
|
August 1, 1983
Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines
A L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
August 1, 1995
Evaluation of Vitek and API 20S for species identification of enterococci
H S Sader, D Biedenbach, R N Jones
Diagnostic Microbiology and Infectious Disease
|
December 1, 1983
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks
R N Jones, A L Barry, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
January 1, 1992
New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria
R N Jones, M E Erwin, M Bale
Diagnostic Microbiology and Infectious Disease
|
February 1, 1996
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials
S Worth, M E Erwin, R N Jones
European Journal of Clinical Microbiology
|
April 1, 1985
Interpretive standards of cefbuperazone disk diffusion susceptibility tests
A L Barry, R N Jones, C Thornsberry
The Journal of Antimicrobial Chemotherapy
|
December 31, 1997
Antimicrobial activity of LB20304, a fluoronaphthyridone, tested against anaerobic bacteria
F Marco, M S Barrett, R N Jones
Lancet (London, England)
|
March 19, 2010
Anuria treated by renal decapsulation and peritoneal dialysis
R REID, J B PENFOLD, R N JONES
Page
of 95